Basic Information
Reprieve Cardiovascular is a leading medical device company focused on improving outcomes for patients with acute decompensated heart failure (ADHF). The company's probation technology is being investigated as an innovative fluid management therapy. It provides clinicians with the ability to precisely control patient fluid volume, which can both enhance cardiac care and help alleviate symptoms in ADHF patients.
Reprieve Cardiovascular, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2018
info@ReprieveCardio.com

